Skip to main content
Caplight Logo









eMed

eMed

Private
Miami, FloridaHealthcare & Life Scienceshttps://emed.com/

Last Round

Series A

Mar 26, 2026

Est. Valuation

$2B

Total Funding Raised

$200M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

eMed is a healthtech company that provides a digital health platform offering telehealth services, at-home diagnostics, and clinically managed GLP-1 weight management programs for employers and individuals.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Medical Devices, Patient Engagement

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

telehealthat-home diagnostic testingremote clinical consultationvirtual carepopulation health managementdigital healthGLP-1 managementpoint-of-care testingPOCTpatient monitoringadherence trackingtelemedicineclinical proctoringdigital health platformemployer health benefitsvirtual clinic

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

eMed Comparables

Compare eMed with similar companies based on industry and business-model similarity.

eMed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Everly Health
83%
LetsGetChecked
80%
Fuze Health
74%

eMed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 26, 2026

Key People

Founding team and executive leadership

Jim Heising

Chief Technology Officer

Executive Team

eMed Investors

Notable investors and investment history

eMed investors
InvestorRounds
Knighthead Capital ManagementSeries A
Paragon BiosciencesSeries A
8VCSeries A
Valor Equity PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Open roles increased to 158, 56% of headcount.

  • Jul 20, 2026

    Open roles increased to 156, 56% of headcount.

eMed Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

eMed Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about eMed's valuation, stock price, and market status.

Firmographic Details

HeadquartersMiami, Florida
Employee Range140
Year Founded2020
Last FundingMar 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?